In VivoA major campaign in biopharma’s war against COVID-19 is the development of effective vaccines against the novel virus. While industry scrambles to repurpose drugs against the disease – antivirals agai
In VivoAs of March 4, 2020, there were more than 93,000 confirmed cases of COVID-19, the newly named disease caused by the coronavirus outbreak that originated in Wuhan, China, at the end of 2019. According
ScripA major campaign in biopharma’s war against COVID-19 is the development of effective vaccines against the novel virus. While industry scrambles to repurpose drugs against the disease – antivirals agai
ScripThe first vaccine for the new coronavirus is officially out of lab and being put to the clinical test, as the outbreak originating from Wuhan in China continues its spread around the world with hundre